← Eichor
Study identifier: NCT06597851 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

Condition: Coronary Microvascular Dysfunction · Coronary Microvascular Disease · Insulin Resistance  ·  Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this prospective study is to assess the correlation between coronary microvascular disfunction and insulin resistance in patients with INOCA. Patients with ANOCA and without diabetes will undergo invasive coronary microvascular assessment through coronary angiography and insulin resistance assessment through hyperinsulinemic-euglycemic clamp test. Patients enrolled in the study will be followed for a period of 2 years to monitor their clinical status.

This description comes directly from the study's public registry record.

Talk to the study team

Natascia Antonioli  ·  0039 0458122320  ·  studi.clinici.cardiologia@aovr.veneto.it

Always discuss trial participation with your own doctor first.

Locations (1)

Azienda Ospedaliera Universitaria di VeronaVerona, VR, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06597851